Breaking News Instant updates and real-time market news.

KPTI

Karyopharm

$8.63

-0.36 (-4.00%)

07:11
09/03/19
09/03
07:11
09/03/19
07:11

Karyopharm reports inducement grants under Nasdaq listing rule

Karyopharm Therapeutics announced that the Compensation Committee of Karyopharm's Board of Directors granted stock options to purchase an aggregate of 39,000 shares of Karyopharm's common stock to five newly-hired employees, with a grant date of August 30, 2019. The stock options were granted as inducements material to the new employees entering into employment with Karyopharm in accordance with NASDAQ Listing Rule 5635(c)(4). Each of the stock options has an exercise price of $8.64 per share, the closing price of Karyopharm's common stock on August 30, 2019. Each stock option vests over four years, with 25% of the original number of shares underlying the stock option vesting on the one-year anniversary of the applicable employee's employment commencement date and an additional 1/48th of the shares vesting monthly thereafter, subject to the employee's continued service as an employee of, or other service provider to, Karyopharm through the applicable vesting dates. In addition, each stock option will be immediately exercisable in full if, on or prior to the first anniversary of the consummation of a "change in control event," the employee's employment is terminated for "good reason" by the employee or terminated without "cause" by Karyopharm.

  • 04

    Sep

  • 04

    Sep

KPTI Karyopharm
$8.63

-0.36 (-4.00%)

07/05/19
WEDB
07/05/19
NO CHANGE
Target $11
WEDB
Outperform
Wedbush boosts Karyopharm target to $11 from $6 on Xpovio approval
Wedbush analyst David Nierengarten raised his price target for Karyopharm Therapeutics to $11 from $6 after the FDA on Wednesday approved selinexor, now branded as Xpovio, in combination with dexamethasone for the treatment of multiple myeloma in patients who have received at least four prior therapies. The stock closed Wednesday up 36% to $8.90. The label has no black box warnings or contraindications, but does include extensive safety monitoring guidelines and recommendations, Nierengarten tells investors in a research note. Karyopharm has priced Xpovio at $22,000 per month, which comes in higher than expected but is "not unreasonable" in comparison to other FDA-approved multiple myeloma drugs, contends the analyst. He projects sales of $9.1M in fiscal 2019, with peak sales potential approaching $300M. Nierengarten keeps an Outperform rating on Karyopharm Therapeutics.
07/23/19
JPMS
07/23/19
UPGRADE
Target $16
JPMS
Overweight
Karyopharm upgraded to Overweight from Neutral at JPMorgan
JPMorgan analyst Eric Joseph upgraded Karyopharm Therapeutics to Overweight from Neutral and doubled his price target for the shares to $16 from $8. The analyst says his doctor survey supports a "strong" Xpovio launch and long-term outlook.
07/23/19
JPMS
07/23/19
UPGRADE
Target $16
JPMS
Overweight
JPMorgan upgrades Karyopharm after doctor survey, doubles price target
JPMorgan analyst Eric Joseph upgraded Karyopharm Therapeutics to Overweight from Neutral and doubled his price target for the shares to $16 from $8. The analyst conducted a U.S. physician survey assessing Xpovio anticipated use in the approved indication of penta-refractory myeloma, as well as expectations around use in earlier-line settings. The survey of 15 doctors data show favorable reception to Xpovio's clinical profile, with 75% respondents intending to write Xpovio for PR-MM within the next 12 months, Joseph tells investors in a research note. Importantly, nearly all respondents described the side-effect profile as manageable, which is "very encouraging," adds the analyst. He sees a favorable reward/risk profile for Karyopharm shares at current levels.
07/23/19
07/23/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Snap (SNAP) upgraded to Buy from Hold at Stifel with analyst John Egbert saying the company's sales reorganization efforts were already reflected in its prior guidance and the daily active user checks for the quarter appear to be positive. 2. Murphy Oil (MUR) upgraded to Buy from Neutral at Goldman Sachs with analyst Brian Singer saying he believes the company's free cash flow generation is being underappreciated by the market. 3. Karyopharm (KPTI) upgraded to Overweight from Neutral at JPMorgan with analyst Eric Joseph saying he conducted a U.S. physician survey assessing Xpovio anticipated use in the approved indication of penta-refractory myeloma, as well as expectations around use in earlier-line settings. The survey of 15 doctors data show favorable reception to Xpovio's clinical profile, with 75% respondents intending to write Xpovio for PR-MM within the next 12 months. 4. Smith & Nephew (SNN) upgraded to Buy from Hold at Berenberg with analyst Tom Jones saying he believes management and process changes have addressed the company's execution issues. He views Smith & Nephew's portfolio as "highly competitive." 5. Columbia Sportswear (COLM) upgraded to Buy from Neutral at BofA/Merrill with analyst Alexander Perry citing his outlook for the company to generate "significant near-term revenue and EPS upside" amid a strong wholesale environment for Columbia's apparel as well as its "significant" under-penetration in footwear. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

USAT

USA Technologies

$7.43

-0.22 (-2.88%)

14:31
09/20/19
09/20
14:31
09/20/19
14:31
Hot Stocks
Breaking Hot Stocks news story on USA Technologies »

USA Technologies trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

USAT

USA Technologies

$7.43

-0.22 (-2.88%)

14:28
09/20/19
09/20
14:28
09/20/19
14:28
Hot Stocks
USA Technologies says unlikely to meet Nasdaq deadline for filing compliance »

USA Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

USAT

USA Technologies

$7.43

-0.22 (-2.88%)

14:26
09/20/19
09/20
14:26
09/20/19
14:26
Hot Stocks
Breaking Hot Stocks news story on USA Technologies »

USA Technologies trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FISV

Fiserv

$104.82

-0.03 (-0.03%)

14:25
09/20/19
09/20
14:25
09/20/19
14:25
Options
Fiserv call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

  • 27

    Oct

TD

Toronto-Dominion

$57.97

0.4 (0.69%)

, DB

Deutsche Bank

$8.02

-0.055 (-0.68%)

14:24
09/20/19
09/20
14:24
09/20/19
14:24
Hot Stocks
TD accepted Epstein accounts after Deutsche cut ties, Bloomberg says »

Canadian lender…

TD

Toronto-Dominion

$57.97

0.4 (0.69%)

DB

Deutsche Bank

$8.02

-0.055 (-0.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

IVV

iShares Core S&P 500

$301.93

-0.845 (-0.28%)

, SPY

SPDR S&P 500 ETF Trust

$298.77

-0.906381 (-0.30%)

14:22
09/20/19
09/20
14:22
09/20/19
14:22
Technical Analysis
On The Fly: Weekly technical notes for S&P 500 »

ETF fund flows to the top…

IVV

iShares Core S&P 500

$301.93

-0.845 (-0.28%)

SPY

SPDR S&P 500 ETF Trust

$298.77

-0.906381 (-0.30%)

HYG

iShares iBoxx $ High Yield Corporate Bond

$87.41

0.05 (0.06%)

IEF

iShares 7-10 Year Treasury Bond ETF

$111.69

0.335 (0.30%)

ITE

SPDR Bloomberg Barclays Intermediate Term Treasury ETF

$62.19

0.065 (0.10%)

SPTL

SPDR Portfolio Long Term Treasury ETF

$40.45

0.12 (0.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

14:17
09/20/19
09/20
14:17
09/20/19
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

14:16
09/20/19
09/20
14:16
09/20/19
14:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PDD

Pinduoduo

$33.65

-0.98 (-2.83%)

14:15
09/20/19
09/20
14:15
09/20/19
14:15
Options
Pinduoduo put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FIT

Fitbit

$4.00

0.3347 (9.13%)

14:11
09/20/19
09/20
14:11
09/20/19
14:11
Periodicals
Fitbit deciding whether to explore sale, Reuters says »

Fitbit (FIT) has held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FIT

Fitbit

$3.69

0.025 (0.68%)

14:07
09/20/19
09/20
14:07
09/20/19
14:07
Hot Stocks
Fitbit rises after report of hiring bank to consider sale »

Shares of Fitbit are…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FIT

Fitbit

$3.73

0.06 (1.64%)

14:03
09/20/19
09/20
14:03
09/20/19
14:03
Periodicals
Breaking Periodicals news story on Fitbit »

Fitbit in talks with bank…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

W

Wayfair

$122.80

-5.865 (-4.56%)

13:55
09/20/19
09/20
13:55
09/20/19
13:55
Options
Wayfair put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DELL

Dell Technologies

$52.26

-0.8 (-1.51%)

13:53
09/20/19
09/20
13:53
09/20/19
13:53
Conference/Events
Dell Technologies to hold a business news update meeting »

CFO Sweet, along with SVP…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 26

    Nov

FTR

Frontier Communications

$1.00

-0.0006 (-0.06%)

13:43
09/20/19
09/20
13:43
09/20/19
13:43
Periodicals
Frontier Communications prepares for debt restructuring talks, WSJ reports »

Frontier Communications…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:40
09/20/19
09/20
13:40
09/20/19
13:40
General news
U.S. equity markets »

U.S. equity markets were…

BTU

Peabody Energy

$15.47

-1.56 (-9.16%)

, ARCH

Arch Coal

$71.00

-5.37 (-7.03%)

13:39
09/20/19
09/20
13:39
09/20/19
13:39
Hot Stocks
Peabody Energy confirms commitment to pending PRB/Colorado joint venture »

Peabody (BTU) confirmed…

BTU

Peabody Energy

$15.47

-1.56 (-9.16%)

ARCH

Arch Coal

$71.00

-5.37 (-7.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

SPY

SPDR S&P 500 ETF Trust

$298.09

-1.586381 (-0.53%)

, SPX

S&P 500

$0.00

(0.00%)

13:34
09/20/19
09/20
13:34
09/20/19
13:34
Periodicals
Chinese delgation cancels farm trip to Montana, Reuters reports »

Chinese officials that…

SPY

SPDR S&P 500 ETF Trust

$298.09

-1.586381 (-0.53%)

SPX

S&P 500

$0.00

(0.00%)

DJX

Dow Jones Industrial Average

$0.00

(0.00%)

NDX

Nasdaq 100 Index

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RACE

Ferrari

$151.80

-1.95 (-1.27%)

13:30
09/20/19
09/20
13:30
09/20/19
13:30
Options
Trader trims risk by legging out of iron condor in Ferrari »

Trader trims risk by…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MGM

MGM Resorts

$29.05

-0.01 (-0.03%)

13:25
09/20/19
09/20
13:25
09/20/19
13:25
Options
MGM Resorts call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$300.00

0.323619 (0.11%)

, SPX

S&P 500

$0.00

(0.00%)

13:22
09/20/19
09/20
13:22
09/20/19
13:22
General news
Breaking General news story on SPDR S&P 500 ETF Trust, S&P 500 »

Montana farm bureau says…

SPY

SPDR S&P 500 ETF Trust

$300.00

0.323619 (0.11%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WMT

Walmart

$117.62

0.58 (0.50%)

, MO

Altria Group

$41.19

1.08 (2.69%)

13:21
09/20/19
09/20
13:21
09/20/19
13:21
Periodicals
Walmart to stop sale of e-cigarettes in stores, Yahoo Finance reports »

Walmart (WMT) will stop…

WMT

Walmart

$117.62

0.58 (0.50%)

MO

Altria Group

$41.19

1.08 (2.69%)

BTI

British American Tobacco

$36.57

0.07 (0.19%)

IMBBY

Imperial Brands

$0.00

(0.00%)

PM

Philip Morris

$72.77

1.07 (1.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 12

    Nov

  • 13

    Nov

  • 14

    Nov

MGM

MGM Resorts

$29.04

-0.02 (-0.07%)

13:21
09/20/19
09/20
13:21
09/20/19
13:21
Periodicals
Breaking Periodicals news story on MGM Resorts »

MGM Resorts in talks to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BTI

British American Tobacco

$36.57

0.07 (0.19%)

, MO

Altria Group

$41.24

1.13 (2.82%)

13:19
09/20/19
09/20
13:19
09/20/19
13:19
Hot Stocks
BTI says product, to its knowledge, not involved in vaping deaths »

British American Tobacco…

BTI

British American Tobacco

$36.57

0.07 (0.19%)

MO

Altria Group

$41.24

1.13 (2.82%)

PM

Philip Morris

$72.78

1.08 (1.51%)

IMBBY

Imperial Brands

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

13:17
09/20/19
09/20
13:17
09/20/19
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.